Research Groups and R&D Platforms: Basic research, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Endocrinology, Metabolic diseases, Obesity, Pharmacology, Receptor, Target discovery
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Neuroendocrine mechanisms in pathogenesis and therapeutics of cardiometabolic diseases
Eriika Savontaus
eriika.savontaus[at]utu.fi
Institute of Biomedicine,
University of Turku
TCDM - Turku Center for Disease Modeling
Basic research, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Endocrinology, Metabolic diseases, Obesity, Pharmacology, Receptor, Target discovery
